van den Hoogen FH - Search Results

1

Decreased staining of heparan sulfate in non-lesional skin of a subgroup of patients with systemic lupus erythematosus.

Seyger MM, van Bruggen MC, Hardeman HK, van den Hoogen FH, Berden JH, van den Born J, De Jong EM. Seyger MM, et al. Among authors: van den born j, van bruggen mc, van den hoogen fh. Acta Derm Venereol. 1998 Sep;78(5):326-30. doi: 10.1080/000155598442971. Acta Derm Venereol. 1998. PMID: 9779246 Free article.

2

Clinical aspects of systemic and localized scleroderma.

van den Hoogen FH, de Jong EM. van den Hoogen FH, et al. Curr Opin Rheumatol. 1995 Nov;7(6):546-50. doi: 10.1097/00002281-199511000-00014. Curr Opin Rheumatol. 1995. PMID: 8579977 Review.

3

Reliability of two methods to assess morphea: skin scoring and the use of a durometer.

Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Seyger MM, et al. Among authors: van den hoogen fh. J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):793-6. doi: 10.1016/s0190-9622(97)70121-x. J Am Acad Dermatol. 1997. PMID: 9366834 Free article. Clinical Trial. No abstract available.

4

Low-dose methotrexate in the treatment of widespread morphea.

Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Seyger MM, et al. Among authors: van den hoogen fh. J Am Acad Dermatol. 1998 Aug;39(2 Pt 1):220-5. doi: 10.1016/s0190-9622(98)70079-9. J Am Acad Dermatol. 1998. PMID: 9704833 Clinical Trial.

5

A patient with a severe scleroedema diabeticorum, partially responding to low-dose methotrexate.

Seyger MM, van den Hoogen FH, de Mare S, van Haelst U, de Jong EM. Seyger MM, et al. Among authors: van den hoogen fh, van haelst u. Dermatology. 1999;198(2):177-9. doi: 10.1159/000018103. Dermatology. 1999. PMID: 10325473 No abstract available.

6

Systemic sclerosis: new insights in autoimmunity.

Kaal SE, van Den Hoogen FH, de Jong EM, Viëtor HE. Kaal SE, et al. Among authors: van den hoogen fh. Proc Soc Exp Biol Med. 1999 Oct;222(1):1-8. doi: 10.1111/j.1525-1373.1999.09991.x. Proc Soc Exp Biol Med. 1999. PMID: 10510242 Review.

7

Localized and systemic scleroderma show different histological responses to methotrexate therapy.

Seyger MM, van den Hoogen FH, van Vlijmen-Willems IM, van de Kerkhof PC, de Jong EM. Seyger MM, et al. Among authors: van den hoogen fh, van de kerkhof pc, van vlijmen willems im. J Pathol. 2001 Apr;193(4):511-6. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH779>3.0.CO;2-8. J Pathol. 2001. PMID: 11276011

8

[Systemic lupus erythematosus].

van den Hoogen FH. van den Hoogen FH. Ned Tijdschr Tandheelkd. 1992 Sep;99(9):343-4. Ned Tijdschr Tandheelkd. 1992. PMID: 11820004 Review. Dutch. No abstract available.

9

Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice.

den Broeder AA, de Jong E, Franssen MJ, Jeurissen ME, Flendrie M, van den Hoogen FH. den Broeder AA, et al. Among authors: van den hoogen fh. Ann Rheum Dis. 2006 Jun;65(6):760-2. doi: 10.1136/ard.2004.033662. Epub 2005 Nov 3. Ann Rheum Dis. 2006. PMID: 16269431 Free PMC article.

10

Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study.

den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, de Waal-Malefijt M, van den Hoogen FH. den Broeder AA, et al. Among authors: van den hoogen fh. J Rheumatol. 2007 Apr;34(4):689-95. J Rheumatol. 2007. PMID: 17117492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters